Cargando…

1175. Extended Infusion Beta-lactams in Pediatric Patients with Febrile Neutropenia

BACKGROUND: Febrile neutropenia (FN) is associated with a high risk for infections in patients receiving chemotherapy. Mortality estimates in pediatric patients with FN range from 0.4-3%. Extended infusion (EI) of beta-lactam antibiotics leads to improved pharmacodynamic parameters and is associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagel, Jerod, Davidge, Karen, King, Madeleine, Al-Ajmi, Abdullah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679097/ http://dx.doi.org/10.1093/ofid/ofad500.1015

Ejemplares similares

P1554: SYSTEMATIC REVIEW OF EXTENDED VERSUS BOLUS INFUSION OF BROAD-SPECTRUM BETA-LACTAM ANTIBIOTICS FOR FEBRILE NEUTROPENIA
por: Ishikawa, Kazuhiro, et al.
Publicado: (2023)

253. Febrile Neutropenia Antibiotic De-escalation Study in Acute Myeloid Leukemia Patients With Prolonged Neutropenia
por: Alegria, William, et al.
Publicado: (2018)

Effectiveness of Extended or Continuous vs. Bolus Infusion of Broad-Spectrum Beta-Lactam Antibiotics for Febrile Neutropenia: A Systematic Review and Meta-Analysis
por: Ishikawa, Kazuhiro, et al.
Publicado: (2023)

2676. Effect of β-Lactam Allergy on Appropriateness of Antibiotic Use in Patients with Febrile Neutropenia
por: Yetmar, Zachary A, et al.
Publicado: (2019)

1680. Characterization of Ethanol Lock Use and Line Infections in Pediatric Patients with Intestinal Failure Requiring Central Venous Access
por: Davidge, Karen, et al.
Publicado: (2023)

1550. Pediatric Febrile Neutropenia: Does Depth and Duration of Neutropenia at Presentation Predict Outcomes?
por: Alali, Muayad, et al.
Publicado: (2018)

962. Impact of Care Bundle Element Compliance on Clinical Outcomes for Pediatric Patients with Staphylococcus aureus Bacteremia
por: Pallotta, Raneem, et al.
Publicado: (2023)

1951. Extended Infusions of Β-lactam Antibiotics are Feasible and May Improve Mortality in the Pediatric Population
por: Schortemeyer, Rachael L, et al.
Publicado: (2019)

Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE)
por: Laporte-Amargos, J., et al.
Publicado: (2020)

242. Comprehensive Pathogen Detection for Pediatric Febrile Neutropenia by Metagenomic Next-Generation Sequencing
por: Horiba, Kazuhiro, et al.
Publicado: (2019)

203. Evaluating the Impact of Extended-Infusion Beta-Lactam Therapy on Clinical Outcomes and the Subsequent Emergence of Resistance in Adults with Gram-Negative Bloodstream Infections
por: Karaba, Sara M, et al.
Publicado: (2023)

Impact of an Extended Infusion Β-lactam Strategy on Outcomes in Critically Ill Patients with Pseudomonas Infections
por: Klinker, Kenneth, et al.
Publicado: (2017)

1175. Tandem Heart-Associated Fevers: Does the Fever Signify Infection?
por: Hasan, Mustafa, et al.
Publicado: (2019)

203. Opportunities for Antimicrobial Stewardship in Febrile Neutropenia
por: Shoff, Christopher, et al.
Publicado: (2020)

Prevalence of Fungemia in Pediatric Patients with Febrile Neutropenia
por: Meidani, Mohsen, et al.
Publicado: (2018)

2178. Sensitivity of Blood Cultures in Detection of Bacteremia in Febrile Neutropenia
por: Patel, Vanisha, et al.
Publicado: (2019)

2218. Evaluation of Bacteremia in Febrile Neutropenia and Implications on Antimicrobial Stewardship
por: Kalava, Sowmya, et al.
Publicado: (2023)

Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia: A systematic review and Bayesian network meta-analysis
por: Tan, Xinmei, et al.
Publicado: (2021)

202. The effectiveness of combination therapy of anti-methicillin-resistant Staphylococcus aureus agents and β-lactam agents in patients complicated with febrile neutropenia after bone marrow transplantation
por: Sugiyama, Soichiro, et al.
Publicado: (2019)

1107. Third Generation Cephalosporins Monotherapy Experience in Pediatric Patients with High-Risk Febrile Neutropenia
por: Gutierrez, Valentina, et al.
Publicado: (2020)

1805. Safety Outcomes Following Beta-Lactam use in Patients with a Documented Beta-Lactam Allergy
por: Rampersad, Daniel, et al.
Publicado: (2022)

92. Utility of Sinus CT in the Evaluation of Patients with Febrile Neutropenia
por: Gurram, Pooja, et al.
Publicado: (2020)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

1181. Evaluation of the Safety of a Beta-Lactam Allergy Protocol
por: Sakowski, Alexandra K, et al.
Publicado: (2023)

1175. Clinical and Microbiological Features of Klebsiella pneumoniae Liver Abscess Caused by Multidrug-Resistant Strains
por: Lin, Yi-Tsung, et al.
Publicado: (2018)

722. Risk Factors for Infection or Colonization with Ceftolozane/Tazobactam Non-Susceptible Extensively β-Lactam Resistant Pseudomonas aeruginosa
por: Lee, Michelle, et al.
Publicado: (2023)

Quality Initiative to Improve time to Antibiotics for Febrile Pediatric Patients with Potential Neutropenia
por: Monroe, Kathy, et al.
Publicado: (2018)

Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
por: Cennamo, Federica, et al.
Publicado: (2021)

Evaluation of risk stratification strategies in pediatric patients with febrile neutropenia()
por: Janssens, Keegan Peter, et al.
Publicado: (2020)

Bloodstream infection in pediatric patients with febrile neutropenia induced by chemotherapy
por: Lima, Mariana Antunes Faria, et al.
Publicado: (2023)

Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia
por: Tran, Nikki N, et al.
Publicado: (2023)

394 Influence of febrile neutropenia on the pharmacokinetics and dosage requirements of vancomycin
por: Shiotsuka, Shouichi, et al.
Publicado: (2014)

1598. Oral Step Down Therapy With Levofloxacin for Low-Risk Febrile Neutropenia in Children
por: Mehra, Sonia, et al.
Publicado: (2018)

2532. Identifying Educational Needs and Improving Provider Knowledge Regarding the Management of Febrile Neutropenia
por: Chang, Amy, et al.
Publicado: (2019)

Beta-lactam antibiotics in continuous infusion in critically ill patients
por: Jeurissen, Axel, et al.
Publicado: (2010)

1175. Pulmonary Aspergillosis in Critically Ill Patients with COVID-19: A Case Series
por: Mitaka, Hayato, et al.
Publicado: (2020)

1175. Influenza Vaccine Hesitancy in Hospitalized Children, Before and During the COVID-19 Pandemic
por: Orbea, Marisa, et al.
Publicado: (2021)

64. Absolute Monocyte Count (AMC) as Early and Safe Marker for Discharge in Low-risk Pediatric Febrile Neutropenia with Cancer
por: Alali, Muayad, et al.
Publicado: (2021)

Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011)

Febrile neutropenia with bacterial paronychia
por: Hosono, Yuki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3emjtmmg2v20u17s2i9fmjncfg